GoHealth, Inc. (GOCO) quarterly income statement — complete revenue, gross profit & net income history
| Revenue | 11.91M | 12.64M | 34.19M | 94.05M | 220.97M | 389.13M | 118.29M | 105.87M | 185.6M | 276.7M | 132.04M | 142.78M |
| Revenue Growth % | -94.61% | -96.75% | -71.1% | -11.17% | 19.06% | 40.63% | -10.41% | -25.85% | 1.33% | 298.84% | -0.76% | -10.01% |
| Medical Costs & Claims | 8.93M | -5.48M | 20.09M | 32.41M | 23.51M | 52.24M | 23.51M | 20.68M | 38.01M | 41.09M | 35.99M | 36.42M |
| Medical Cost Ratio % | 74.97% | -43.33% | 58.78% | 34.46% | 10.64% | 13.42% | 19.88% | 19.53% | 20.48% | 14.85% | 27.26% | 25.51% |
| Gross Profit | 2.98M | 18.12M | 14.09M | 61.64M | 197.46M | 336.9M | 94.78M | 85.19M | 147.59M | 235.61M | 96.05M | 106.36M |
| Gross Margin % | 25.03% | 143.33% | 41.22% | 65.54% | 89.36% | 86.58% | 80.12% | 80.47% | 79.52% | 85.15% | 72.74% | 74.49% |
| Gross Profit Growth % | -98.49% | -94.62% | -85.13% | -27.65% | 33.79% | 42.99% | -1.32% | -19.9% | 7.18% | 383.34% | 12.98% | -1.14% |
| Operating Expenses | 37.78M | 50.38M | 302.01M | 161.02M | 190.79M | 256.63M | 137.45M | 125.8M | 151.62M | 220.55M | 134.02M | 159.37M |
| OpEx / Revenue % | 317.07% | 398.63% | 883.43% | 171.21% | 86.34% | 65.95% | 116.2% | 118.82% | 81.69% | 79.71% | 101.5% | 111.62% |
| Depreciation & Amortization | 307K | 410K | 27.02M | 26.2M | 26.48M | 26.93M | 26.42M | 26.3M | 26.25M | 26.85M | 26.27M | 26.37M |
| Combined Ratio % | 392.04% | 355.3% | 942.21% | 205.68% | 96.98% | 79.37% | 136.07% | 138.36% | 102.17% | 94.56% | 128.76% | 137.13% |
| Operating Income | -34.79M | -32.27M | -287.92M | -99.39M | 7.38M | 80.27M | -42.67M | -40.61M | -4.03M | 15.06M | -37.98M | -53.02M |
| Operating Margin % | -292.04% | -255.3% | -842.21% | -105.68% | 3.34% | 20.63% | -36.07% | -38.36% | -2.17% | 5.44% | -28.76% | -37.13% |
| Operating Income Growth % | -571.53% | -140.2% | -574.72% | -144.73% | 283.01% | 432.98% | -12.37% | 23.4% | 29.87% | 111.31% | 35.79% | 47.53% |
| EBITDA | -34.49M | -31.86M | -260.89M | -73.19M | 33.86M | 107.19M | -16.25M | -14.31M | 22.21M | 41.91M | -11.71M | -26.65M |
| EBITDA Margin % | -289.47% | -252.05% | -763.16% | -77.82% | 15.32% | 27.55% | -13.74% | -13.52% | 11.97% | 15.15% | -8.87% | -18.66% |
| Interest Expense | 30.79M | 29.66M | 24.76M | 16.95M | 15.95M | 17.73M | 19.09M | 18.1M | 17.95M | 17.75M | 17.57M | 17.27M |
| Non-Operating Income | -156K | -266K | 1.73M | 11K | 109K | 2.17M | -77.11M | 648K | -566K | -776K | 771K | 21K |
| Pretax Income | -65.42M | -61.66M | -314.4M | -116.34M | -8.68M | 60.36M | 15.36M | -59.35M | -21.42M | -1.92M | -56.31M | -70.3M |
| Pretax Margin % | -549.14% | -487.86% | -919.69% | -123.7% | -3.93% | 15.51% | 12.98% | -56.06% | -11.54% | -0.69% | -42.65% | -49.24% |
| Income Tax | 712K | -3.6M | -486K | -353K | 1.1M | 2.39M | -11K | -40K | -71K | 379K | -108K | -73K |
| Effective Tax Rate % | -1.09% | 5.84% | 0.15% | 0.3% | -12.69% | 3.96% | -0.07% | 0.07% | 0.33% | -19.79% | 0.19% | 0.1% |
| Net Income | -37.17M | -32.59M | -165.85M | -54.28M | -4.41M | 25.51M | 6.78M | -26M | -9.22M | -1.23M | -23.91M | -28.94M |
| Net Margin % | -311.99% | -257.89% | -485.13% | -57.71% | -1.99% | 6.56% | 5.73% | -24.55% | -4.97% | -0.44% | -18.11% | -20.27% |
| Net Income Growth % | -743.26% | -227.78% | -2547.91% | -108.79% | 52.17% | 2180.67% | 128.34% | 10.18% | -0.4% | 98% | 20.31% | 33.95% |
| EPS (Diluted) | -2.36 | -2.08 | -13.52 | -5.10 | -0.52 | 1.50 | 0.46 | -2.70 | -0.95 | -0.22 | -2.61 | -3.27 |
| EPS Growth % | -353.85% | -238.67% | -3039.13% | -88.89% | 45.26% | 781.82% | 117.62% | 17.43% | 15.18% | 96.86% | 23.46% | 38.07% |
| EPS (Basic) | -2.36 | -2.08 | -13.52 | -5.10 | -0.52 | 2.42 | 0.58 | -2.70 | -0.95 | -0.22 | -2.61 | -3.27 |
| Diluted Shares Outstanding | 16.2M | 12.94M | 11.88M | 10.6M | 10.37M | 16.37M | 14.58M | 9.97M | 9.71M | 9.58M | 9.49M | 9.12M |